<DOC>
	<DOCNO>NCT02842983</DOCNO>
	<brief_summary>After initial hemodynamic stabilization , 36 septic shock patient heart rate &gt; 90 bpm require norepinephrine maintain mean arterial pressure ( MAP ) 65 mmHg randomise two group , esmolol group control group . Patients allocate esmolol group receive continuous esmolol infusion maintain lower heart rate 10 % . Norepinephrine titrate achieve MAP 65 mmHg . To investigate myocardial performance , investigator assess Tissue Doppler image echocardiography hemodynamic measure . Data obtain baseline , esmolol infusion achieve predefined heart rate threshold 72hours esmolol infusion .</brief_summary>
	<brief_title>Pilot Study : Echocardiographic Hemodynamic Effects Esmolol Septic Shock Patients</brief_title>
	<detailed_description>primary outcome determine accord previous study tissue doppler .</detailed_description>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Esmolol</mesh_term>
	<mesh_term>Adrenergic beta-1 Receptor Antagonists</mesh_term>
	<criteria>septic shock fluid optimization cardiac index &gt; 3 l/min/m2 Heart Rate &gt; 90 /min Cardiogenic shock Bradycardia History Severe Asthma Indications Esmolol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Esmolol</keyword>
	<keyword>Hypotension</keyword>
	<keyword>Shock , Septic</keyword>
	<keyword>Sepsis</keyword>
	<keyword>Systemic Inflammatory Response Syndrome</keyword>
	<keyword>Adrenergic beta-1 Receptor Antagonists</keyword>
	<keyword>Adrenergic Antagonists</keyword>
	<keyword>Pharmacologic Actions</keyword>
	<keyword>Physiological Effects Drugs</keyword>
</DOC>